Mason Emily F, Pozdnyakova Olga, Li Betty, Dudley Graham, Dorfman David M
Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Am J Clin Pathol. 2017 Jul 1;148(1):33-41. doi: 10.1093/ajcp/aqx041.
The importance of distinguishing mature B-cell lymphoproliferative disorders (B-LPDs) is highlighted by the distinct treatments used for and varying prognoses seen in association with these different diseases. Immunophenotyping allows for accurate and efficient differentiation of many B-LPDs. Recently, we showed that CD200 is highly expressed in hairy cell leukemia (HCL) but not in marginal zone lymphoma (MZL), lymphoplasmacytic lymphoma (LPL), or hairy cell leukemia-variant (HCL-v). Here, we assessed the usefulness of a flow cytometric panel combining CD200 and CD1d with CD25, CD103, and CD11c to distinguish CD10-, CD5- B-LPDs.
We analyzed the expression of CD200 and CD1d by flow cytometric analysis in 79 cases of CD10-, CD5- mature B-LPDs.
Distinct patterns of CD200 and CD1d expression were seen in the examined B-LPDs. HCL showed bright positivity for CD200 along with positive staining for CD1d, whereas HCL-v showed low levels of expression for both markers. LPL demonstrated positive staining for CD200 in combination with dim to negative staining for CD1d. In contrast, MZL was commonly positive for CD1d and negative for CD200.
Flow cytometric analysis of CD200 and CD1d, along with CD25, CD103, and CD11c, can aid in the diagnosis of CD10-, CD5- mature B-LPDs.
不同成熟B细胞淋巴增殖性疾病(B-LPDs)的治疗方法不同,预后也各异,因此鉴别这些疾病具有重要意义。免疫表型分析有助于准确、高效地区分多种B-LPDs。最近,我们发现CD200在毛细胞白血病(HCL)中高表达,但在边缘区淋巴瘤(MZL)、淋巴浆细胞淋巴瘤(LPL)或变异型毛细胞白血病(HCL-v)中不表达。在此,我们评估了将CD200、CD1d与CD25、CD103和CD11c联合使用的流式细胞术检测组合在鉴别CD10-、CD5- B-LPDs中的作用。
我们采用流式细胞术分析了79例CD10-、CD5-成熟B-LPDs中CD200和CD1d的表达情况。
在所检测的B-LPDs中观察到CD200和CD1d的不同表达模式。HCL显示CD200强阳性,同时CD1d染色阳性,而HCL-v则显示这两种标志物的低表达水平。LPL表现为CD200染色阳性,同时CD1d染色弱阳性至阴性。相比之下,MZL通常CD1d阳性,CD200阴性。
对CD200、CD1d以及CD25、CD103和CD11c进行流式细胞术分析,有助于诊断CD10-、CD5-成熟B-LPDs。